Isabelle Hubert-Fouchard
Angers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.
Journal: Journal of hepatology
Published: April 07, 2022
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 21, 2020
Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres.
Journal: Alimentary pharmacology & therapeutics
Published: May 22, 2019
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
Journal: Clinical and translational gastroenterology
Published: April 23, 2019
Doppler ultrasonography devices, including elastography, allow for accurate diagnosis of severe liver fibrosis.
Journal: European journal of radiology
Published: May 31, 2018
Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 12, 2018
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
Journal: Kidney international
Published: November 17, 2017
A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis.
Journal: Hepatology communications
Published: October 26, 2017
A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.
Journal: Journal of hepatology
Published: October 21, 2016
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C.
Journal: World journal of hepatology
Published: September 25, 2016
Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
Journal: Journal of gastroenterology and hepatology
Published: May 30, 2016
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.
Journal: Journal of hepatology
Published: May 10, 2016
Last Updated: 09/26/2026